Literature DB >> 19076063

Genetic determinants and molecular pathways in the pathogenesis of Type 2 diabetes.

Wanzhu Jin1, Mary-Elizabeth Patti.   

Abstract

T2DM (Type 2 diabetes mellitus) has reached epidemic proportions worldwide, exerting major health consequences at an individual and public health level alike. Unfortunately, the molecular pathophysiology of diabetes remains incompletely understood, impairing progress towards more effective prevention and treatment strategies. Although the rapid increase in the prevalence of insulin resistance and T2DM over the past several decades highlights a major environmental contribution related to overnutrition, obesity and inactivity, susceptibility is likely to reflect individual differences in complex gene-environment interactions. In the present review, we focus on mediators of genetic and environmental risk for T2DM at a molecular level.

Entities:  

Mesh:

Year:  2009        PMID: 19076063     DOI: 10.1042/CS20080090

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  28 in total

1.  PRMT1 promotes glucose toxicity-induced β cell dysfunction by regulating the nucleo-cytoplasmic trafficking of PDX-1 in a FOXO1-dependent manner in INS-1 cells.

Authors:  Lixia Lv; Hewen Chen; Jiaying Sun; Di Lu; Chen Chen; Dongfang Liu
Journal:  Endocrine       Date:  2015-02-10       Impact factor: 3.633

2.  GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease.

Authors:  Yazhou Li; Kara B Duffy; Mary Ann Ottinger; Balmiki Ray; Jason A Bailey; Harold W Holloway; David Tweedie; Tracyann Perry; Mark P Mattson; Dimitrios Kapogiannis; Kumar Sambamurti; Debomoy K Lahiri; Nigel H Greig
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Increased SRF transcriptional activity in human and mouse skeletal muscle is a signature of insulin resistance.

Authors:  Wanzhu Jin; Allison B Goldfine; Tanner Boes; Robert R Henry; Theodore P Ciaraldi; Eun-Young Kim; Merve Emecan; Connor Fitzpatrick; Anish Sen; Ankit Shah; Edward Mun; Vokes Vokes; Joshua Schroeder; Elizabeth Tatro; Jose Jimenez-Chillaron; Mary-Elizabeth Patti
Journal:  J Clin Invest       Date:  2011-03       Impact factor: 14.808

4.  Hyperlipidemia and the development of diabetic retinopathy: Comparison between type 1 and type 2 animal models.

Authors:  Renu A Kowluru; Manish Mishra; Anjaneyulu Kowluru; Binit Kumar
Journal:  Metabolism       Date:  2016-07-30       Impact factor: 8.694

5.  Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits.

Authors:  Ayellet V Segrè; Leif Groop; Vamsi K Mootha; Mark J Daly; David Altshuler
Journal:  PLoS Genet       Date:  2010-08-12       Impact factor: 5.917

Review 6.  Epigenetic mechanisms in the development of type 2 diabetes.

Authors:  Sara E Pinney; Rebecca A Simmons
Journal:  Trends Endocrinol Metab       Date:  2009-10-26       Impact factor: 12.015

7.  Protein Tyrosine Phosphatase Non-receptor 22 Gene C1858T Polymorphism in Patients with Coexistent Type 2 Diabetes and Hashimoto's Thyroiditis.

Authors:  Funda Bulut; Deniz Erol; Halit Elyas; Halil Doğan; Fethi Ahmet Ozdemir; Lezan Keskin
Journal:  Balkan Med J       Date:  2014-03-01       Impact factor: 2.021

8.  Intrauterine Growth Retardation - A Developmental Model of Type 2 Diabetes.

Authors:  Sara E Pinney
Journal:  Drug Discov Today Dis Models       Date:  2013

9.  Retinopathy in a Diet-Induced Type 2 Diabetic Rat Model and Role of Epigenetic Modifications.

Authors:  Renu A Kowluru
Journal:  Diabetes       Date:  2020-01-16       Impact factor: 9.461

Review 10.  Developmental and environmental epigenetic programming of the endocrine pancreas: consequences for type 2 diabetes.

Authors:  Ionel Sandovici; Constanze M Hammerle; Susan E Ozanne; Miguel Constância
Journal:  Cell Mol Life Sci       Date:  2013-03-06       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.